Metropolitan Life Insurance CO Ocular Therapeutix, Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.85 - $10.93 $7,334 - $20,821	1,905 Added 45.35%	6,106 $55,000
Q1 2023 May 15, 2023	SELL	$2.79 - $6.27 $1,297 - $2,915	-465 Reduced 9.97%	4,201 $22,000
Q4 2022 Jun 14, 2023	BUY	$2.61 - $4.41 $1,213 - $2,050	465 Added 11.07%	4,666 $13.1 Million
Q3 2022 Jun 14, 2023	BUY	$4.09 - $6.5 $1,901 - $3,022	465 Added 11.07%	4,666 $19.4 Million
Q3 2022 Mar 30, 2023	BUY	$4.09 - $6.5 $9,173 - $14,579	2,243 Added 92.57%	4,666 $19,000
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $9,173 - $14,579	2,243 Added 92.57%	4,666 $19,000
Q2 2022 Jun 20, 2023	SELL	$3.01 - $5.22 $5,351 - $9,281	-1,778 Reduced 42.32%	2,423 $9,000
Q2 2022 Mar 30, 2023	SELL	$3.01 - $5.22 $7,901 - $13,702	-2,625 Reduced 52.0%	2,423 $9,000
Q2 2022 Aug 11, 2022	SELL	$3.01 - $5.22 $7,901 - $13,702	-2,625 Reduced 52.0%	2,423 $10,000
Q1 2022 Jun 20, 2023	BUY	$4.83 - $7.35 $4,091 - $6,225	847 Added 20.16%	5,048 $24,000
Q1 2022 Mar 30, 2023	SELL	$4.83 - $7.35 $65,958 - $100,371	-13,656 Reduced 73.01%	5,048 $24,000
Q1 2022 May 12, 2022	SELL	$4.83 - $7.35 $65,958 - $100,371	-13,656 Reduced 73.01%	5,048 $25,000
Q4 2021 Jun 21, 2023	BUY	$6.16 - $12.07 $89,338 - $175,051	14,503 Added 345.23%	18,704 $130,000
Q4 2021 Mar 30, 2023	SELL	$6.16 - $12.07 $8,008 - $15,691	-1,300 Reduced 6.5%	18,704 $130,000
Q4 2021 Feb 15, 2022	SELL	$6.16 - $12.07 $8,008 - $15,691	-1,300 Reduced 6.5%	18,704 $130,000
Q3 2021 Jun 21, 2023	BUY	$9.7 - $14.34 $153,289 - $226,615	15,803 Added 376.17%	20,004 $200,000
Q2 2021 Jun 21, 2023	BUY	$13.43 - $19.16 $212,234 - $302,785	15,803 Added 376.17%	20,004 $283,000
Q2 2021 Mar 30, 2023	BUY	$13.43 - $19.16 $27,222 - $38,837	2,027 Added 11.28%	20,004 $283,000
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $268,411 - $382,931	19,986 Added 111033.33%	20,004 $284,000
Q1 2021 Jun 26, 2023	BUY	$15.82 - $22.11 $217,936 - $304,587	13,776 Added 327.92%	17,977 $295 Million
Q1 2021 Mar 30, 2023	SELL	$15.82 - $22.11 $13,035 - $18,218	-824 Reduced 4.38%	17,977 $295,000
Q1 2021 May 14, 2021	SELL	$15.82 - $22.11 $297,147 - $415,292	-18,783 Reduced 99.9%	18 $295,000
Q4 2020 Jun 22, 2023	BUY	$7.91 - $22.95 $115,486 - $335,070	14,600 Added 347.54%	18,801 $389,000
Q3 2020 Jun 26, 2023	BUY	$7.36 - $9.87 $107,456 - $144,102	14,600 Added 347.54%	18,801 $143,000
Q3 2020 Mar 30, 2023	BUY	$7.36 - $9.87 $26,135 - $35,048	3,551 Added 23.29%	18,801 $143,000
Q3 2020 Nov 13, 2020	BUY	$7.36 - $9.87 $26,135 - $35,048	3,551 Added 23.29%	18,801 $143,000
Q2 2020 Jun 26, 2023	BUY	$4.67 - $8.95 $51,598 - $98,888	11,049 Added 263.01%	15,250 $127,000
Q2 2020 Mar 30, 2023	BUY	$4.67 - $8.95 $1,905 - $3,651	408 Added 2.75%	15,250 $127,000
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $1,905 - $3,651	408 Added 2.75%	15,250 $127,000
Q1 2020 Jul 12, 2023	BUY	$3.95 - $7.4 $42,031 - $78,743	10,641 Added 253.3%	14,842 $73,000
Q1 2020 Mar 30, 2023	BUY	$3.95 - $7.4 $40,195 - $75,302	10,176 Added 218.09%	14,842 $73,000
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $58,625 - $109,830	14,842 New	14,842 $73,000
Q3 2018 Nov 14, 2018	SELL	$5.42 - $6.99 $66,443 - $85,690	-12,259 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$5.99 - $8.17 $73,431 - $100,156	12,259 New	12,259 $0
Q3 2017 Nov 14, 2017	SELL	$5.28 - $6.88 $90,588 - $118,040	-17,157 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	17,157	17,157 $159,000

Others Institutions Holding OCUL

# of Institutions

171

Shares Held

138M

Call Options Held

150K

Put Options Held

225K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $699M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account